HGF

HGF

HGF 분자 정보

Molecule Name
Hepatocyte growth factor
분자 별명
HGF,HPTA,SF
Drug Development Progress
임상 약물 수7
시판 약물 수1
최고 연구 개발 단계Approved
표적 별명
EC 3.4.21.7,Hepatocyte Growth Factor (Hepapoietin A; Scatter Factor),EC 3.4.21,HGF,Hepatopoietin-A,Scatter factor,Hepatocyte Growth Factor (Hepapoietin A,Scatter Factor),Fibroblast-Derived Tumor Cytotoxic Factor,Lung Fibroblast-Derived Mitogen,SF,Deafness, Autosomal Recessive 39,Hepatopoietin A,DFNB39,F-TCF,HGFB,Hepatocyte Growth Factor,HPTA
분자 배경
Hepatocyte growth factor (HGF) is a paracrine cellular growth, motility and morphogenic factor. Activating ligand for the receptor tyrosine kinase MET by binding to it and promoting its dimerization. Hepatocyte growth factor is secreted by mesenchymal cells and acts as a multi-functional cytokine on cells of mainly epithelial origin. Its ability to stimulate mitogenesis, cell motility, and matrix invasion gives it a central role in angiogenesis, tumorogenesis, and tissue regeneration. In addition, HGF has been implicated in a variety of cancers, including of the lungs, pancreas, thyroid, colon, and breast.

HGF 제품 목록

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
FosgonimetonNDX-1017; ATH-1017; ATH 1017Phase 3 ClinicalM3 Biotechnology
Alzheimer Disease; Dementia; Lewy Body Disease; Parkinson Disease
상세
RGL-2102RGL-2102; RGL2102Phase 3 ClinicalShanghai Regenelead Therapies Co Ltd
Diabetic Foot; Ischemia; Ulcer; Wound Infection
상세
FiclatuzumabAV-299; SCH-900105Phase 3 ClinicalAveo
Carcinoma, Basal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cholangiocarcinoma; Colonic Neoplasms; Glioblastoma; Head and Neck Neoplasms; Leukemia, Myeloid, Acute; Liver Neoplasms; Lung Neoplasms; Lymphoma; Multiple Myeloma; Oropharyngeal Neoplasms; Pancreatic Neoplasms; Respiratory Tract Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck
상세
UmikibartYYB-101; NOV-1105; CLM-101Phase 2 ClinicalYooYoung Pharmaceutical Co Ltd
Colorectal Neoplasms; Solid tumours
상세
ATH-1020ATH-1020Phase 1 ClinicalAthira Pharma Inc
Nerve Degeneration
상세
ATH-1105ATH-1105Phase 1 ClinicalAthira Pharma Inc
Amyotrophic Lateral Sclerosis; Frontotemporal Dementia
상세
Microbiome-optimized autologous stem cell therapy (Biotech Holdings)ClinicalBiotech Holdings
Peripheral Vascular Diseases
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
Beperminogene perplasmidAMG-0001-01; AMG-0001; DS-992; TREAT-HGFApprovedAnges Mg, Osaka UniversityCollategeneJapanPeripheral Arterial Disease; IschemiaAnges Inc, null2019-03-01
Arterial Occlusive Diseases; Atherosclerosis; Foot Ulcer; Ischemia; Peripheral Arterial Disease; Peripheral Vascular Diseases; Ulcer; Vascular Diseases
상세